We are live on ! Find out more
BLPH

Bellerophon Therapeutics, Inc.

Delisted

BLPH was delisted on the 13th of October, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
NMVA
1
New Mountain Vantage Advisers
New York
$8.6M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$2.09M -$110K -3,994 -5%
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$260K +$5.46K +199 +2%
Vanguard Group
4
Vanguard Group
Pennsylvania
$151K
LPL Financial
5
LPL Financial
California
$80K -$23.1K -843 -21%
BIT
6
BlackRock Institutional Trust
California
$50K
Renaissance Technologies
7
Renaissance Technologies
New York
$37K +$37.8K +1,380 New
Creative Planning
8
Creative Planning
Kansas
$34K +$11.7K +426 +50%
VKH
9
Virtu KCG Holdings
New York
$29K +$29.9K +1,089 New
GA
10
Geneva Advisors
Illinois
$22K
TSS
11
Two Sigma Securities
New York
$22K +$23.5K +858 New
Citadel Advisors
12
Citadel Advisors
Florida
$21K +$22.1K +806 New
UBS Group
13
UBS Group
Switzerland
$1K -$795 -29 -36%
Morgan Stanley
14
Morgan Stanley
New York
$1K
TRCT
15
Tower Research Capital (TRC)
New York
$1K
Walleye Trading
16
Walleye Trading
New York
$1K
BCM
17
Bridgeway Capital Management
Texas
-$246K -6,667 Closed
Jacobs Levy Equity Management
18
Jacobs Levy Equity Management
New Jersey
-$78K -2,119 Closed
BFA
19
BlackRock Fund Advisors
California
-$23K -614 Closed
Bank of America
20
Bank of America
North Carolina
-$2.19K -80 Closed
BIM
21
BlackRock Investment Management
Delaware
-$2K -56 Closed
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
+$329 +12 New